S1P2 contributes to microglial activation and M1 polarization following cerebral ischemia through ERK1/2 and JNK

Sphingosine 1-phosphate (S1P) signaling has emerged as a drug target in cerebral ischemia. Among S1P receptors, S1P 2 was recently identified to mediate ischemic brain injury. But, pathogenic mechanisms are not fully identified, particularly in view of microglial activation, a core pathogenesis in c...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports 2019-08, Vol.9 (1), p.1-13, Article 12106
Main Authors: Sapkota, Arjun, Gaire, Bhakta Prasad, Kang, Min-Gu, Choi, Ji Woong
Format: Article
Language:English
Subjects:
13/21
13/51
631/378/1689/534
631/378/2596/1953
64/60
Brain injury
Cerebral blood flow
Extracellular signal-regulated kinase
Humanities and Social Sciences
Ischemia
Lipopolysaccharides
Microglia
multidisciplinary
NF-κB protein
Pathogenesis
Polarization
Reperfusion
Science
Science (multidisciplinary)
Sphingosine 1-phosphate
Traumatic brain injury
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sphingosine 1-phosphate (S1P) signaling has emerged as a drug target in cerebral ischemia. Among S1P receptors, S1P 2 was recently identified to mediate ischemic brain injury. But, pathogenic mechanisms are not fully identified, particularly in view of microglial activation, a core pathogenesis in cerebral ischemia. Here, we addressed whether microglial activation is the pathogenesis of S1P 2 -mediated brain injury in mice challenged with transient middle cerebral artery occlusion (tMCAO). To suppress S1P 2 activity, its specific antagonist, JTE013 was given orally to mice immediately after reperfusion. JTE013 administration reduced the number of activated microglia and reversed their morphology from amoeboid to ramified microglia in post-ischemic brain after tMCAO challenge, along with attenuated microglial proliferation. Moreover, JTE013 administration attenuated M1 polarization in post-ischemic brain. This S1P 2 -directed M1 polarization appeared to occur in activated microglia, which was evidenced upon JTE013 exposure in vivo as suppressed M1-relevant NF-κB activation in activated microglia of post-ischemic brain. Moreover, JTE013 exposure or S1P 2 knockdown reduced expression levels of M1 markers in vitro in lipopolysaccharide-driven M1 microglia. Additionally, suppressing S1P 2 activity attenuated activation of M1-relevant ERK1/2 and JNK in post-ischemic brain or lipopolysaccharide-driven M1 microglia. Overall, our study demonstrated that S1P 2 regulated microglial activation and M1 polarization in post-ischemic brain.
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-019-48609-z